General Information of DME (ID: DER0XCH)

DME Name Farnesol dehydrogenase (AKR1B15) DME Info
Gene Name AKR1B15

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
3 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [1]
Estrone DM5T6US Acne vulgaris ED80 Approved [1]
Testosterone cypionate DMC1TEV N. A. N. A. Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ANDROSTERONE DMITJAK N. A. N. A. Phase 3 [1]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nitrobenzaldehyde DM4UHB5 N. A. N. A. Investigative [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Aldo-keto Reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates. J Biol Chem. 2015 Mar 6;290(10):6531-45.
2 Functional expression of novel human and murine AKR1B genes. Chem Biol Interact. 2011 May 30;191(1-3):177-84.